JPRN-jRCTs031180140进行中（未招募）1 期
Phase I/II study of HSCT from HLA-matched donor using post-transplant cyclophosphamide - HLA-matched PT/CY
Chiba Shigeru0 个研究点目标入组 20 人开始时间: 2019年2月20日最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 16age old 至 <= 60age old（—）
- 性别
- All
入选标准
- •1) AML, ALL, NHL, MDS
- •2) age 16-60
- •3) possessing allele 8/8 matched donor (age 16-60)
- •4) PS =< 2
- •5) EF >= 40%
- •6) SpO2 >= 90%
- •7) %VC >= 70% and FEV1.0% >= 70%
- •8) Bil =< 2.0 mg/dl
- •9) Ccr >= 30 ml/min
排除标准
- •1) positive for HBs Ag
- •2) positive for HIV Ab
- •3) depression
- •4) pregnancy
- •5) coexisting active cancer
- •6) active infection
- •7) pentostatin administration
- •8) hypersensitivity to cyclophosphamide
研究者
相似试验
尚未招募
1 期
Phase I/II study of HSCT from HLA-matched donor using post-transplant cyclophosphamideAML, ALL, NHL. MDSJPRN-UMIN000028779niversity of Tsukuba20
Unknown
不适用
Allogeneic HCT Using Uniform Conditioning Regimen Regardless of Donors (MS, MU, or HF) for AML in RemissionAcute Myeloid LeukemiaNCT03337568Asan Medical Center110
已完成
1 期
A phase I/II trial of HLA haploidentical peripheral blood stem cell transplantation following reduced-intensity conditioningChronic myeloid leukemia, Acute myeloid leukemia, Acute lymphoid leukemia, Myelodysplastic syndrome, Malignant lymphomaJPRN-C000000253Health and Labour Sciences Research Grants, Research on Human Genome, Tissue Engineering, Ministry of Health, Labour and Welfare25
进行中（未招募）
2 期
HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation CyclophosphamideAcute Myelogenous LeukemiaMyelodysplastic SyndromesLymphomaChronic Lymphocytic LeukemiaAcute Lymphoblastic LeukemiaChronic Myelogenous LeukemiaAcute LeukemiaMixed Phenotype Acute LeukemiaNCT04904588Center for International Blood and Marrow Transplant Research300
终止
1 期
Donor Stem Cell Transplant in Treating Patients With High Risk Acute Myeloid LeukemiaAdult Acute Megakaryoblastic Leukemia (M7)Adult Acute Monoblastic Leukemia (M5a)Adult Acute Monocytic Leukemia (M5b)Adult Acute Myeloblastic Leukemia With Maturation (M2)Adult Acute Myeloblastic Leukemia Without Maturation (M1)Adult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)Adult Acute Myelomonocytic Leukemia (M4)Adult Erythroleukemia (M6a)Adult Pure Erythroid Leukemia (M6b)Childhood Acute Erythroleukemia (M6)Childhood Acute Megakaryocytic Leukemia (M7)Childhood Acute Monoblastic Leukemia (M5a)Childhood Acute Monocytic Leukemia (M5b)Childhood Acute Myeloblastic Leukemia With Maturation (M2)Childhood Acute Myeloblastic Leukemia Without Maturation (M1)Childhood Acute Myeloid Leukemia in RemissionChildhood Acute Myelomonocytic Leukemia (M4)Recurrent Adult Acute Myeloid LeukemiaRecurrent Childhood Acute Myeloid LeukemiaSecondary Acute Myeloid LeukemiaUntreated Adult Acute Myeloid LeukemiaUntreated Childhood Acute Myeloid Leukemia and Other Myeloid MalignanciesNCT01801046University of Southern California10